Fluorescent SNAP-tag galectin fusion proteins as novel tools in glycobiology

Current Pharmaceutical Design

Volumn 19, Issue 30, 2013, Pages 5457-5467

  Kupper, Christiane E ^a   Böcker, Sophia ^a   Liu, Hulong ^a   Adamzyk, Carina ^a   van de Kamp, Julia ^a   Recker, Tobias ^a   Lethaus, Bernd ^b   Jahnen Dechent, Willi ^a   Neuss, Sabine ^a   Müller Newen, Gerhard ^a   Elling, Lothar ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Fluorescent protein; Fusion protein; Galectin 1; Galectin 3; Mesenchymal stem cells; SNAP tag

Indexed keywords

ALKALINE PHOSPHATASE; ASIALOFETUIN; BENZYLGUANINE; BETA GALACTOSIDE; BINDING PROTEIN; COMPLEMENTARY DNA; FETUIN; GALECTIN; GALECTIN 1; GALECTIN 3; GLYCAN; GUANINE DERIVATIVE; HYBRID PROTEIN; LACTOSE; RECOMBINANT PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN;

ABSORPTION SPECTROSCOPY; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE; GEL PERMEATION CHROMATOGRAPHY; GLYCOBIOLOGY; HUMAN; HUMAN CELL; MEDICAL TECHNOLOGY; MESENCHYMAL STEM CELL; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SHEEP; SNAP TAG TECHNOLOGY;

ASIALOGLYCOPROTEINS; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; FETUINS; GALECTINS; HUMANS; LUMINESCENT PROTEINS; MESENCHYMAL STROMAL CELLS; MOLECULAR IMAGING; PROTEIN BINDING; RECOMBINANT PROTEINS; TRANSFERRIN;

EID: 84881327081     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319300017     Document Type: Article

References (105)

1. Barondes SH, Cooper DNW, Gitt MA, Leffler H. Galectins structure and function of a large family of animal lectins. J Biol Chem 1994; 269: 20807-10.
2. Cooper DN. Galectinomics: Finding themes in complexity. Biochim Biophys Acta 2002; 1572: 209-31.
3. Almkvist J, Karlsson A. Galectins as inflammatory mediators. Glycoconj J 2004; 19: 575-81.
4. Elola MT, Wolfenstein-Todel C, Troncoso MF, Vasta GR, Rabinovich GA. Galectins: Matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci 2007; 64: 1679-700.
5. Hernandez JD, Baum LG. Ah, sweet mystery of death! Galectins and control of cell fate. Glycobiology 2002; 12: 127-36.
6. Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta 2002; 1572: 263-73.
7. Liu F-T, Rabinovich GA. Galectins as modulators of tumor progression. Nat Rev 2005; 5: 29-41.
8. Rabinovich GA, Toscano MA. Turning 'sweet' on immunity: Galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 2009; 9: 338-52.
9. John CM, Leffler H, Kahl-Knutsson B, Svensson I, Jarvis GA. Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer. Clin Cancer Res 2003; 9: 2374-83.
10. Johnson KD, Glinskii OV, Mossine VV et al. Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia. Neoplasia 2007; 9: 662-70.
11. Papaspyridonos M, McNeill E, de Bono JP et al. Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction. Arterioscler Thromb Vasc Biol 2008; 28: 433-40.
12. Pieters RJ. Inhibition and detection of galectins. ChemBioChem 2006; 7: 721-8.
13. Dings RPM, Miller MC, Nesmelova I et al. Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding. J Med Chem 2012; 55: 5121-9.
14. Dings RPM, Van Laar ES, Loren M et al. Inhibiting tumor growth by targeting tumor vasculature with galectin-1 antagonist anginex conjugated to the cytotoxic acylfulvene, 6-hydroxylpropylacylfulvene. Bioconjug Chem 2010; 21: 20-7.
15. Chen SJ, Lin CC, Tuan WC, Tseng CS, Huang RN. Effect of recombinant galectin-1 on the growth of immortal rat chondrocyte on chitosan-coated plga scaffold. J Biomed Mater Res A 2005; 93A: 1482-92.
16. Marcon P, Marsich E, Vetere A et al. The role of galectin-1 in the interaction between chondrocytes and a lactose-modified chitosan. Biomaterials 2005; 26: 4975-84.
17. Römer CE, Elling L. Galectins: Structures, binding properties and function in cell adhesion. In: Pignatello R. Ed. Biomaterials physics and chemistry. InTech 2011; pp. 3-28.
18. Sauerzapfe B, Krenek K, Schmiedel J et al. Chemo-enzymatic synthesis of poly-n-acetyllactosamine (poly-lacnac) structures and their characterization for cgl2-galectin-mediated binding of ecm glycoproteins to biomaterial surfaces. Glycoconj J 2009; 26: 141-59.
19. Levy Y, Arbel-Goren R, Hadari YR et al. Galectin-8 functions as a matricellular modulator of cell adhesion. J Biol Chem 2001; 276: 31285-95.
20. Carlsson S, Oberg CT, Carlsson MC et al. Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology 2007; 17: 663-76.
21. Rapoport EM, Andre S, Kurmyshkina OV et al. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: A case study on galectins-1 and -3 and the impact of assay setting. Glycobiology 2008; 18: 315-324.
22. Salomonsson E, Carlsson MC, Osla V et al. Mutational tuning of galectin-3 specificity and biological function. J Biol Chem 2010; 285: 35079-91.
23. Blixt O, Head S, Mondala T et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA 2004; 101: 17033-17038.
24. Song XZ, Xia BY, Stowell SR et al. Novel fluorescent glycan microarray strategy reveals ligands for galectins. Chem Biol 2009; 16: 36-47.
25. Stowell SR, Arthur CM, Mehta P et al. Galectin-1,-2, and-3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem 2008; 283: 10109-23.
26. Patnaik SK, Potvin B, Carlsson S et al. Complex n-glycans are the major ligands for galectin-1, -3, and -8 on chinese hamster ovary cells. Glycobiology 2006; 16: 305-17.
27. Stowell SR, Arthur CM, Slanina KA et al. Dimeric galectin-8 induces phosphatidylserine exposure in leukocytes through polylactosamine recognition by the c-terminal domain. J Biol Chem 2008; 283: 20547-59.
28. de Melo FHM, Butera D, Medeiros RS et al. Biological applications of a chimeric probe for the assessment of galectin-3 ligands. J Histochem Cytochem 2007; 55: 1015-1026.
29. Carlsson MC, Balog CIA, Kilsgård O et al. Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease. Biochim Biophys Acta 2012; 1820: 1366-72.
30. Hirabayashi J, Hashidate T, Arata Y et al. Oligosaccharide specificity of galectins: A search by frontal affinity chromatography. Biochim Biophys Acta 2002; 1572: 232-54.
31. Propheter DC, Hsu KL, Mahal LK. Fabrication of an oriented lectin microarray. ChemBioChem 2010; 11: 1203-7.
32. Hussain AF, Kampmeier F, von Felbert V et al. Snap-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cells. Bioconjug Chem 2011; 22: 2487-95.
33. Engin S, Trouillet V, Franz CM et al. Benzylguanine thiol self-assembled monolayers for the immobilization of snap-tag proteins on microcontact-printed surface structures. Langmuir 2010; 26: 6097-101.
34. Kindermann M, George N, Johnsson N, Johnsson K. Covalent and selective immobilization of fusion proteins. J Am Chem Soc 2003; 125: 7810-1.
35. Recker T, Haamann D, Schmitt A et al. Directed covalent immobilization of fluorescently labeled cytokines. Bioconjug Chem 2011; 22: 1210-20.
36. Gronemeyer T, Godin G, Johnsson K. Adding value to fusion proteins through covalent labeling. Curr Opin Biotechnol 2005; 16: 453-8.
37. Juillerat A, Heinis C, Sielaff I et al. Engineering substrate specificity of o-6-alkylguanine-DNA alkyltransferase for specific protein labeling in living cells. ChemBioChem 2005; 6: 1263-9.
38. Keppler A, Pick H, Arrivoli C, Vogel H, Johnsson K. Labeling of fusion proteins with synthetic fluorophores in live cells. Proc Natl Acad Sci USA 2004; 101: 9955-9.
39. Maduzia LL, Yu E, Zhang YH. Caenorhabditis elegans galectins lec-6 and lec-10 interact with similar glycoconjugates in the intestine. J Biol Chem 2011; 286: 4371-81.
40. Witten KG, Rech C, Eckert T et al. Glyco-DNA-gold nanoparticles: Lectin-mediated assembly and dual-stimuli response. Small 2011; 7: 1954-60.
41. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976; 72: 248-54.
42. Wang H, He L, Lensch M et al. Single-site cys-substituting mutation of human lectin galectin-2: Modulating solubility in recombinant production, reducing long-term aggregation, and enabling site-specific monopegylation. Biomacromolecules 2008; 9: 3223-30.
43. Kupper CE, Rosencrantz RR, Henßen B et al. Chemo-enzymatic modification of poly-n-acetyllactosamine (lacnac) oligomers and n,n-diacetyllactosamine (lacdinac) based on galactose oxidase treatment. Beilstein J Org Chem 2012; 8: 712-25.
44. Rech C, Rosencrantz RR, Krenek K et al. Combinatorial one-pot synthesis of poly-n-acetyllactosamine oligosaccharides with leloirglycosyltransferases. Adv Synth Catal 2011; 353: 2492-500.
45. Haynesworth S, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992; 13: 81-8.
46. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
47. Neuss S, Becher E, Woltje M, Tietze L, Jahnen-Dechent W. Functional expression of hgf and hgf receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells 2004; 22: 405-14.
48. Neuss S, Denecke B, Gan L et al. Transcriptome analysis of msc and msc-derived osteoblasts on resomer (r) lt706 and pcl: Impact of biomaterial substrate on osteogenic differentiation. Plos One 2011; 6.
49. Mrugala D, Bony C, Neves N et al. Phenotypic and functional characterisation of ovine mesenchymal stem cells: Application to a cartilage defect model. Ann Rheum Dis 2008; 67: 288-95.
50. McCarty RC, Gronthos S, Zannettino AC, Foster BK, Xian CJ. Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol 2009; 219: 324-33.
51. Patnaik SK, Stanley P. Lectin resistant cho glycosylation mutants. In: Minoru F. Ed. Methods in enzymology. Academic Press 2006; pp. 159-82.
52. Cederfur C, Salomonsson E, Nilsson J et al. Different affinity of galectins for human serum glycoproteins: Galectin-3 binds many protease inhibitors and acute phase proteins. Glycobiology 2008; 18: 384-94.
53. Szabo Z, Guttman A, Rejtar T, Karger BL. Improved sample preparation method for glycan analysis of glycoproteins by ce-lif and ce-ms. Electrophoresis 2010; 31: 1389-95.
54. Pasek M, Boeggeman E, Ramakrishnan B, Qasba PK. Galectin-1 as a fusion partner for the production of soluble and folded human beta-1,4-galactosyltransferase-t7 in e. Coil. Biochem Biophys Res Commun 2010; 394: 679-84.
55. Patterson G, Day RN, Piston D. Fluorescent protein spectra. J Cell Sci 2001; 114: 837-8.
56. Baird GS, Zacharias DA, Tsien RY. Biochemistry, mutagenesis, and oligomerization of dsred, a red fluorescent protein from coral. Proc Natl Acad Sci USA 2000; 97: 11984-9.
57. Gross LA, Baird GS, Hoffman RC, Baldridge KK, Tsien RY. The structure of the chromophore within dsred, a red fluorescent protein from coral. Proc Natl Acad Sci USA 2000; 97: 11990-5.
58. Dumic J, Dabelic S, Flogel M. Galectin-3: An open-ended story. Biochim Biophys Acta 2006; 1760: 616-35.
59. Kuwabara I, Liu FT. Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 1996; 156: 3939-44.
60. Yamaoka A, Kuwabara I, Frigeri LG, Liu FT. A human lectin, galectin-3 (-bp/mac-2), stimulates superoxide production by neutrophils. J Immunol 1995; 154: 3479-87.
61. Cho M, Cummings RD. Galectin-1, a -galactoside-binding lectin in chinese hamster ovary cells. I. Physical and chemical characterization. J Biol Chem 1995; 270: 5198-206.
62. Morris S, Ahmad N, Andre S et al. Quaternary solution structures of galectins-1, -3, and -7. Glycobiology 2004; 14: 293-300.
63. Hsu DK, Zuberi RI, Liu FT. Biochemical and biophysical characterization of human recombinant ige-binding protein, an stype animal lectin. J Biol Chem 1992; 267: 14167-74.
64. Massa SM, Cooper DNW, Leffler H, Barondes SH. L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity. Biochemistry 1993; 32: 260-7.
65. Ochieng J, Platt D, Tait L et al. Structure-function relationship of a recombinant human galactoside-binding protein. Biochemistry 1993; 32: 4455-60.
66. Ahmad N, Gabius HJ, Andre S et al. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem 2004; 279: 10841-7.
67. Arumugham RG, Hsieh TC, Tanzer ML, Laine RA. Structures of the asparagine-linked sugar chains of laminin. Biochim Biophys Acta 1986; 883: 112-26.
68. Knibbs RN, Perini F, Goldstein IJ. Structure of the major concanavalin-a reactive oligosaccharides of the extracellular-matrix component laminin. Biochemistry 1989; 28: 6379-92.
69. Ido H, Harada K, Futaki S et al. Molecular dissection of the alphadystroglycan and integrin-binding sites within the globular domain of human laminin-10. J Biol Chem 2004; 279: 10946-54.
70. Martin PT. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Glycobiology 2003; 13: 55-66.
71. Sato S, Hughes RC. Binding-specificity of a baby hamster-kidney lectin for h type-i and type-ii chains, polylactosamine glycans, and appropriately glycosylated forms of laminin and fibronectin. J Biol Chem 1992; 267: 6983-990.
72. Leppänen A, Stowell S, Blixt O, Cummings RD. Dimeric galectin-1 binds with high affinity to 2,3-sialylated and non-sialylated terminal n-acetyllactosamine units on surface-bound extended glycans. J Biol Chem 2005; 280: 5549-62.
73. Stowell SR, Dias-Baruffi M, Penttila L et al. Human galectin-1 recognition of poly-n-acetyllactosamine and chimeric polysaccharides. Glycobiology 2004; 14: 157-67.
74. Di Virgilio S, Glushka J, Moremen K, Pierce M. Enzymatic synthesis of natural and c-13 enriched linear poly-n-acetyllactosamines as ligands for galectin-1. Glycobiology 1999; 9: 353-64.
75. Zhou Q, Cummings RD. L-14 lectin recognition of laminin and its promotion of in vitro cell adhesion. Arch Biochem Biophys 1993; 300: 6-17.
76. Hirvonen T, Suila H, Kotovuori A et al. The i blood group antigen as a marker for umbilical cord blood-derived mesenchymal stem cells. Stem Cells and Development 2012; 21: 455-64.
77. Hong YJ, Stanley P. Lec3 chinese hamster ovary mutants lack udpn-acetylglucosamine 2-epimerase activity because of mutations in the epimerase domain of the gne gene. J Biol Chem 2003; 278: 53045-54.
78. North SJ, Huang HH, Sundaram S et al. Glycomics profiling of chinese hamster ovary cell glycosylation mutants reveals n-glycans of a novel size and complexity. J Biol Chem 2010; 285: 5759-75.
79. Heiskanen A, Hirvonen T, Salo H et al. Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J 2009; 26: 367-84.
80. Zhuo Y, Bellis SL. Emerging role of 2,6-sialic acid as a negative regulator of galectin binding and function. J Biol Chem 2011; 286: 5935-41.
81. Alon R, Rosen S. Rolling on n-linked glycans: A new way to present l-selectin binding sites. Nat Immunol 2007; 8: 339-341.
82. Lanctot PM, Gage FH, Varki AP. The glycans of stem cells. Curr Opin Chem Biol 2007; 11: 373-80.
83. Rentsch C, Hess R, Rentsch B et al. Ovine bone marrow mesenchymal stem cells: Isolation and characterization of the cells and their osteogenic differentiation potential on embroidered and surface-modified polycaprolactone-co-lactide scaffolds. In vitro Cell Dev Biol Anim 2010; 46: 624-34.
84. Liu XC, Scouten WH. Studies on oriented and reversible immobilization of glycoprotein using novel boronate affinity gel. J Mol Recognit 1996; 9: 462-7.
85. Green ED, Adelt G, Baenziger JU, Wilson S, Van Halbeek H. The asparagine-linked oligosaccharides on bovine fetuin. Structural analysis of n-glycanase-released oligosaccharides by 500-megahertz 1h nmr spectroscopy. J Biol Chem 1988; 263: 18253-68.
86. Nilsson B, Norden NE, Svensson S. Structural studies on the carbohydrate portion of fetuin. J Biol Chem 1979; 254: 4545-53.
87. Spiro RG. Studies on fetuin, a glycoprotein of fetal serum 2. Nature of carbohydrate units. J Biol Chem 1962; 237: 382-8.
88. Dam TK, Gabius HJ, Andre S et al. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. Biochemistry 2005; 44: 12564-71.
89. Hong MF, Cassely A, Mechref Y, Novotny MV. Sugar-lectin interactions investigated through affinity capillary electrophoresis. J Chromatogr B 2001; 752: 207-16.
90. Huang YP, Mechref Y, Novotny MV. Microscale nonreductive release of o-linked glycans for subsequent analysis through maldi mass spectrometry and capillary electrophoresis. Anal Chem 2001; 73: 6063-9.
91. Kamerke C, Pattky M, Huhn C, Elling L. Synthesis of udpactivated oligosaccharides with commercial -galactosidase from bacillus circulans under microwave irradiation. J Mol Catal B-Enzym 2012; 79: 27-34.
92. Knibbs RN, Agrwal N, Wang JL, Goldstein IJ. Carbohydrate-binding protein-35 2. Analysis of the interaction of the recombinant polypeptide with saccharides. J Biol Chem 1993; 268: 14940-7.
93. Spiro RG. Studies on fetuin, a glycoprotein of fetal serum 1. Isolation, chemical composition, and physicochemical properties. J Biol Chem 1960; 235: 2860-9.
94. Charlwood J, Clayton P, Keir G, Mian N, Winchester B. Defective galactosylation of serum transferrin in galactosemia. Glycobiology 1998; 8: 351-7.
95. Mann KG, Fish WW, Cox AC, Tanford C. Single-chain nature of human serum transferrin. Biochemistry 1970; 9: 1348-54.
96. Ryan PA, Pancholi V, Fischetti VA. Group a streptococci bind to mucin and human pharyngeal cells through sialic acid-containing receptors. Infect Immun 2001; 69: 7402-12.
97. Wu ZJ, Miller E, Agbandje-McKenna M, Samulski RJ. 2,3 and 2,6 n-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J Virol 2006; 80: 9093-103.
98. Leffler H, Barondes SH. Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian galactosides. J Biol Chem 1986; 261: 10119-26.
99. Kaltner H, Kubler D, Lopez-Merino L et al. Toward comprehensive analysis of the galectin network in chicken: Unique diversity of galectin-3 and comparison of its localization profile in organs of adult animals to the other four members of this lectin family. Anat Rec Adv Int Anat Evol Biol 2011; 294: 427-44.
100. Hughes RC. Galectins as modulators of cell adhesion. Biochimie 2001; 83: 667-676.
101. Beer MV, Rech C, Gasteier P et al. The next step in biomimetic material design: Poly-lacnac-mediated reversible exposure of extra cellular matrix components. Adv Healthcare Mat 2012.
102. Carlsson MC, Cederfur C, Schaar V et al. Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients. Plos One 2011; 6.
103. Durand G, Seta N. Protein glycosylation and diseases: Blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin Chem 2000; 46: 795-805.
104. Wada Y, Nishikawa A, Okamoto N et al. Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun 1992; 189: 832-6.
105. Flahaut C, Michalski JC, Danel T, Humbert MH, Klein A. The effects of ethanol on the glycosylation of human transferrin. Glycobiology 2003; 13: 191-8.